35 Recruiting Studies Using Ramucirumab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Ramucirumab
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
📍 HonorHealth Research Institute — Scottsdale, Arizona
Solid Tumor
View Study & Checklist ➔A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer
📍 Memorial Sloan Kettering Monmouth (All Protocol Activities) — Middletown, New Jersey
Non Small Cell Lung Cancer
View Study & Checklist ➔Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
📍 Veterans Administration Medical Center - Birmingham — Birmingham, Alabama
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
View Study & Checklist ➔A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Metastatic Esophageal Carcinoma
View Study & Checklist ➔Volrustomig Priming Regimens Exploratory Phase II Platform Study
📍 Research Site — Los Angeles, California
Non-small Cell Lung Cancer
View Study & Checklist ➔Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Recurrent Lung Non-Small Cell Carcinoma
View Study & Checklist ➔Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade
📍 Grady Health System — Atlanta, Georgia
Metastatic Non-Small Lung Cell Cancer
View Study & Checklist ➔A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)
📍 UCLA Hematology/Oncology - Santa Monica — Los Angeles, California
Metastatic Non-Small Cell Lung Cancer
View Study & Checklist ➔Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
📍 Mayo Clinic- Minnesota — Rochester, Minnesota
Gastric Cancer
View Study & Checklist ➔A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
📍 The University of Arizona Cancer Center — Tucson, Arizona
Biliary Tract Cancer
View Study & Checklist ➔Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
📍 Georgetown University — Washington D.C., District of Columbia
Non Small Cell Lung Cancer
View Study & Checklist ➔Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC
📍 NYU Langone — New York, New York
Non Small Cell Lung Cancer
View Study & Checklist ➔A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
📍 The Oncology Institute of Hope & Innovation — Anaheim, California
Gastric Cancer
View Study & Checklist ➔Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma
📍 Washington University School of Medicine — St Louis, Missouri
Recurrent Head and Neck Cancer
View Study & Checklist ➔AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
📍 Research Site — Mobile, Alabama
Gastric Cancer
View Study & Checklist ➔Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
📍 Veterans Administration Medical Center - Birmingham — Birmingham, Alabama
Advanced Lung Non-Small Cell Carcinoma
View Study & Checklist ➔Abemaciclib Plus Ramucirumab for Esophageal/Gastroesophageal Junction Ca
📍 Baylor University Medical Center, Charles A Sammons Cancer Center — Dallas, Texas
Metastatic Esophageal Adenocarcinoma
View Study & Checklist ➔Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
📍 Northwestern University — Chicago, Illinois
Clinical Stage II Esophageal Adenocarcinoma AJCC v8
View Study & Checklist ➔Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
📍 Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis — Daphne, Alabama
Recurrent Lung Non-Small Cell Carcinoma
View Study & Checklist ➔A Study of ASP1002 in Adults for Treatment of Solid Tumors
📍 Yale University Cancer Center — New Haven, Connecticut
Advanced Solid Tumors
View Study & Checklist ➔Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
📍 Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis — Daphne, Alabama
Recurrent Lung Non-Small Cell Carcinoma
View Study & Checklist ➔Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Metastatic Small Intestinal Adenocarcinoma
View Study & Checklist ➔Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Clinical Stage III Gastric Cancer AJCC v8
View Study & Checklist ➔A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
📍 University of California Irvine Medical Center — Orange, California
Gastric Adenocarcinoma
View Study & Checklist ➔A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
📍 Childrens Hospital of Alabama — Birmingham, Alabama
Neoplasms
View Study & Checklist ➔Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
📍 University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 8927) — Tucson, Arizona
Gastroesophageal Junction
View Study & Checklist ➔Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas
📍 Massachusetts General Hospital — Boston, Massachusetts
HER2-negative
View Study & Checklist ➔Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
📍 Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis — Daphne, Alabama
Recurrent Lung Non-Small Cell Carcinoma
View Study & Checklist ➔Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
📍 Baptist Health Medical Center - Little Rock — Little Rock, Arkansas
Advanced Esophageal Adenocarcinoma
View Study & Checklist ➔Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma
📍 Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
Gastroesophageal Adenocarcinoma
View Study & Checklist ➔A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
📍 Research Site — Phoenix, Arizona
Advanced or Metastatic Non-small Cell Lung Cancer
View Study & Checklist ➔Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases
📍 City of Hope Medical Center — Duarte, California
Clinical Stage IVB Gastric Cancer AJCC v8
View Study & Checklist ➔A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
📍 Research Site — Santa Monica, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
📍 City of Hope — Duarte, California
Gastric Adenocarcinoma
View Study & Checklist ➔Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
📍 Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania
Non-small Cell Lung Cancer
View Study & Checklist ➔